PT1114861E - Gene ly6h - Google Patents
Gene ly6h Download PDFInfo
- Publication number
- PT1114861E PT1114861E PT99943357T PT99943357T PT1114861E PT 1114861 E PT1114861 E PT 1114861E PT 99943357 T PT99943357 T PT 99943357T PT 99943357 T PT99943357 T PT 99943357T PT 1114861 E PT1114861 E PT 1114861E
- Authority
- PT
- Portugal
- Prior art keywords
- gene
- ly6h
- protein
- present
- cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26355098 | 1998-09-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1114861E true PT1114861E (pt) | 2007-01-31 |
Family
ID=17391112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT99943357T PT1114861E (pt) | 1998-09-17 | 1999-09-16 | Gene ly6h |
Country Status (17)
Country | Link |
---|---|
US (4) | US7432363B2 (xx) |
EP (1) | EP1114861B8 (xx) |
JP (1) | JP4403443B2 (xx) |
KR (1) | KR100640265B1 (xx) |
CN (1) | CN1240834C (xx) |
AT (1) | ATE346923T1 (xx) |
AU (1) | AU767878B2 (xx) |
BR (1) | BR9913850A (xx) |
CA (1) | CA2342770C (xx) |
CY (1) | CY1107552T1 (xx) |
DE (1) | DE69934239T8 (xx) |
DK (1) | DK1114861T3 (xx) |
ES (1) | ES2276531T3 (xx) |
HK (1) | HK1038380A1 (xx) |
ID (1) | ID29573A (xx) |
PT (1) | PT1114861E (xx) |
WO (1) | WO2000017345A1 (xx) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1114861B8 (en) * | 1998-09-17 | 2008-10-01 | Otsuka Pharmaceutical Co., Ltd. | Ly6h gene |
CA2459161A1 (en) | 2001-08-31 | 2003-03-13 | The Rockefeller University | Phosphodiesterase activity and regulation of phosphodiesterase 1b-mediated signaling in brain |
DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
RU2432362C2 (ru) | 2005-11-30 | 2011-10-27 | Эбботт Лэборетриз | Моноклональные антитела и их применения |
BRPI0619249A2 (pt) | 2005-11-30 | 2011-09-20 | Abbott Lab | anticorpos anti-globulÈmeros-aß, frações que se ligam a antìgeno destes, hibridomas correspondentes, ácidos nucléicos, vetores, células hospedeiras, métodos de produzir os ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos de usar os ditos anticorpos |
US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
CN101663407B (zh) * | 2007-02-22 | 2017-08-08 | 健泰科生物技术公司 | 用于检测炎性肠病的方法 |
EP2486928A1 (en) | 2007-02-27 | 2012-08-15 | Abbott GmbH & Co. KG | Method for the treatment of amyloidoses |
WO2011016861A2 (en) | 2009-08-05 | 2011-02-10 | Intra-Cellular Therapies, Inc. | Novel regulatory proteins and inhibitors |
WO2011130377A2 (en) | 2010-04-15 | 2011-10-20 | Abbott Laboratories | Amyloid-beta binding proteins |
WO2012024187A1 (en) | 2010-08-14 | 2012-02-23 | Abbott Laboratories | Amyloid-beta binding proteins |
US20140286910A1 (en) * | 2013-03-19 | 2014-09-25 | Nikolai Tankovich | Stem cells and methods incorporating environmental factors as a means for enhancing stem cell proliferation and plasticity |
CN105385754B (zh) * | 2015-10-28 | 2018-11-06 | 北京泱深生物信息技术有限公司 | 一种与胆管癌相关的分子标记物 |
KR102232200B1 (ko) * | 2019-03-13 | 2021-03-25 | 아주대학교산학협력단 | 알츠하이머치매 진단 바이오마커 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5011912A (en) | 1986-12-19 | 1991-04-30 | Immunex Corporation | Hybridoma and monoclonal antibody for use in an immunoaffinity purification system |
JPH0348696A (ja) * | 1989-07-14 | 1991-03-01 | Toray Ind Inc | ヒトリンパ球表面抗原およびそれをコードする遺伝子 |
AU4594696A (en) * | 1995-11-13 | 1997-06-05 | Human Genome Sciences, Inc. | Human stem cell antigen 2 |
AU2095299A (en) * | 1997-12-31 | 1999-07-19 | Incyte Pharmaceuticals, Inc. | Human signal peptide-containing proteins |
EP1114861B8 (en) * | 1998-09-17 | 2008-10-01 | Otsuka Pharmaceutical Co., Ltd. | Ly6h gene |
-
1999
- 1999-09-16 EP EP99943357A patent/EP1114861B8/en not_active Expired - Lifetime
- 1999-09-16 DK DK99943357T patent/DK1114861T3/da active
- 1999-09-16 JP JP2000574245A patent/JP4403443B2/ja not_active Expired - Fee Related
- 1999-09-16 CA CA2342770A patent/CA2342770C/en not_active Expired - Fee Related
- 1999-09-16 PT PT99943357T patent/PT1114861E/pt unknown
- 1999-09-16 ES ES99943357T patent/ES2276531T3/es not_active Expired - Lifetime
- 1999-09-16 DE DE69934239T patent/DE69934239T8/de active Active
- 1999-09-16 BR BR9913850-6A patent/BR9913850A/pt not_active Application Discontinuation
- 1999-09-16 WO PCT/JP1999/005039 patent/WO2000017345A1/ja active IP Right Grant
- 1999-09-16 AT AT99943357T patent/ATE346923T1/de active
- 1999-09-16 AU AU56518/99A patent/AU767878B2/en not_active Ceased
- 1999-09-16 CN CNB998110191A patent/CN1240834C/zh not_active Expired - Fee Related
- 1999-09-16 KR KR1020017003354A patent/KR100640265B1/ko not_active IP Right Cessation
- 1999-09-16 ID IDW20010739A patent/ID29573A/id unknown
-
2001
- 2001-12-28 HK HK01109195A patent/HK1038380A1/xx not_active IP Right Cessation
-
2003
- 2003-12-23 US US10/743,018 patent/US7432363B2/en not_active Expired - Fee Related
-
2007
- 2007-02-02 CY CY20071100152T patent/CY1107552T1/el unknown
-
2008
- 2008-02-15 US US12/032,012 patent/US20090017479A1/en not_active Abandoned
- 2008-07-03 US US12/167,288 patent/US7582732B2/en not_active Expired - Fee Related
- 2008-09-30 US US12/242,370 patent/US20100261880A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1114861A1 (en) | 2001-07-11 |
HK1038380A1 (en) | 2002-03-15 |
US20090017479A1 (en) | 2009-01-15 |
DK1114861T3 (da) | 2007-03-19 |
US20100261880A1 (en) | 2010-10-14 |
EP1114861A4 (en) | 2004-10-13 |
CY1107552T1 (el) | 2013-03-13 |
WO2000017345A1 (fr) | 2000-03-30 |
KR100640265B1 (ko) | 2006-10-31 |
US20040254340A1 (en) | 2004-12-16 |
JP4403443B2 (ja) | 2010-01-27 |
US20080275218A1 (en) | 2008-11-06 |
ATE346923T1 (de) | 2006-12-15 |
CA2342770A1 (en) | 2000-03-30 |
CA2342770C (en) | 2011-06-21 |
DE69934239T2 (de) | 2007-06-28 |
KR20010085801A (ko) | 2001-09-07 |
DE69934239T8 (de) | 2007-12-06 |
AU5651899A (en) | 2000-04-10 |
AU767878B2 (en) | 2003-11-27 |
CN1240834C (zh) | 2006-02-08 |
ID29573A (id) | 2001-09-06 |
ES2276531T3 (es) | 2007-06-16 |
CN1318099A (zh) | 2001-10-17 |
BR9913850A (pt) | 2001-10-23 |
DE69934239D1 (de) | 2007-01-11 |
EP1114861B1 (en) | 2006-11-29 |
EP1114861B8 (en) | 2008-10-01 |
US7582732B2 (en) | 2009-09-01 |
US7432363B2 (en) | 2008-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7582732B2 (en) | Ly6h polypeptide | |
WO2003101388A2 (en) | Human solute carrier family 7 member 11 (hslc7a11) | |
JPH10511936A (ja) | ヒトソマトスタチン様受容体 | |
AU2001264247B2 (en) | GASC1 gene | |
EP1048727B1 (en) | Gene encoding novel transmembrane protein | |
US20080248009A1 (en) | Regulation of acheron expression | |
AU767718B2 (en) | Novel mutations in the (FREAC3) gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis | |
CA2408374A1 (en) | Mutation in the .beta.2 nicotinic acetylcholine receptor subunit associated with nocturnal frontal lobe epilepsy | |
JP2002300891A (ja) | 新規化合物 | |
JP2003503026A (ja) | ヒト遺伝子abc1に対応する核酸及びタンパク質 | |
JP4112976B2 (ja) | Pca2501遺伝子 | |
JPH11500004A (ja) | 腫瘍遺伝子Int6のヌクレオチド配列及び推定アミノ酸配列 | |
MXPA01002752A (en) | Ly6h gene | |
JP4147058B2 (ja) | 精神分裂病診断剤 | |
JP4280878B2 (ja) | Masl1遺伝子 | |
JP2001078772A (ja) | Lunx遺伝子及び癌微小転移の検出法 | |
US20030082650A1 (en) | Great gene and protein | |
JP2001025389A (ja) | Tsa7005遺伝子 | |
JP2008118989A (ja) | Pca2501遺伝子 | |
JP2000093177A (ja) | Eos遺伝子 | |
JP2003169688A (ja) | HepNaDC遺伝子 | |
JP2001046072A (ja) | Ace類似遺伝子 | |
JP2002153277A (ja) | K1遺伝子 | |
WO2002020794A1 (fr) | Nouveau polypeptide, acyl-coa synthetase humaine 11.77, et polynucleotide codant ce polypeptide |